WorldOne and Joslin Diabetes Center announced that they have launched the Diabetes HUB, an online clinical and educational resource.
11/20/2013 3:00 PM EST
Today, the Centers for Disease Control (CDC) released the National Health and Nutritional Examination Survey (NHANES) with additional data briefs on hypertension, cholesterol and obesity among adults in the U.S. by age, gender, race and ethnicity.
10/18/2013 1:00 PM EDT
Joslin researchers have gained new insights into how obesity and type 2 diabetes can create a stress response in the brain, especially in the hypothalamus (the brain region that regulates appetite and energy production), that may contribute to...
9/24/2013 1:30 PM EDT
Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes.
9/27/2013 12:30 PM EDT
The National Institutes of Health awarded Joslin Diabetes Center $24.3 million to fund a clinical trial to study a potential treatment for kidney disease in people with type 1 diabetes.
9/26/2013 3:45 PM EDT
Joslin Diabetes Center today announced that Peng Yi, Ph.D., has been appointed an Assistant Investigator in the Islet Cell and Regenerative Biology Section of Joslin’s Research Division.
9/26/2013 9:25 AM EDT
C. Ronald Kahn, M.D., Chief Academic Officer at Joslin Diabetes Center, Awarded the Helmholtz Diabetes Award
The First Helmholtz Diabetes Lecture Award will be presented to C. Ronald Kahn, M.D. at the upcoming Helmholtz-Nature Medicine Diabetes Conference. Dr Kahn is a resident of Newton, MA, and Chief Academic Officer of Joslin Diabetes Center. He will...
9/17/2013 3:40 PM EDT
Good Measures and Joslin Diabetes Center announced today that they have reached an agreement, aimed at incorporating Joslin’s nutritional guidelines, meal plans, exercise recommendations and other relevant resources into Good Measures’ product...
9/6/2013 2:05 PM EDT
11/13/2013 1:00 PM EST
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
3/29/2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
10/1/2010 1:00 PM EDT